Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry Kraemer | M | 69 | 11 years | |
| Lester Knight | M | 65 | 15 years | |
| James Tobin | M | 79 | 22 years | |
| Rick Wallace | M | - | 10 years | |
| Phillip L. Batchelor | M | 62 | - | |
| Gregory Paul Watson | M | 68 | 12 years | |
| Robert Hombach | M | 58 | 26 years | |
| Shashi Karan | M | 70 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | 8 years |
| Marla Persky | F | 68 | 19 years | |
| Alan R. Meyer | M | - |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | - |
| Petros Katsoulas | M | 58 |
University of Aston
| 4 years |
| Brian Anderson | M | 73 | 13 years | |
| Karen May | F | 65 | 15 years | |
| Damian Bunyan | M | 56 |
University of Aston
| 4 years |
| Nancy A. Krejsa | F | 66 | 14 years | |
| Mary Ladone | F | 57 | 16 years | |
| Joanne Quan | M | 60 |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | 4 years |
| Yee Tak Leung | M | 75 |
University of Aston
| 3 years |
| Michael Shapiro | M | 53 | - | |
| Jian Ping Luan | M | 70 |
University of Aston
| 2 years |
| Thomas Sabatino | M | 65 | 14 years | |
| Gary Cust | M | - |
University of Aston
| 2 years |
| Todd F. Davenport | M | 73 | 2 years | |
| Nicholas A. Loiacono | M | 71 | 3 years | |
| Steven C. Collins | M | - | 5 years | |
| Thomas Shippey | M | 49 |
University of Aston
| 4 years |
| Dimitrios Mantzavinos | M | - |
University of Aston
| 2 years |
| James Robert Bareham | M | - |
University of Aston
| 4 years |
| Robert Peterson | M | 67 | 13 years | |
| Peter Campbell | M | 56 |
University of Aston
| 4 years |
| Kim Brady | M | 60 | 4 years | |
| Carsten Brockmeyer | M | - | 7 years | |
| Dan Dobson | M | - | 13 years | |
| Darren Davis | M | - |
University of Aston
| 4 years |
| Yuan Lu | M | 69 |
University of Aston
| 3 years |
| Dimitrios Eleftherios Mantzavinos | M | - |
University of Aston
| 2 years |
| Claire Mccorquodale | F | - |
University of Aston
| 4 years |
| Björk Tórarinsdóttir | M | - | 5 years | |
| Jacqueline Kunzler | M | 58 | - | |
| Haim Izrael | M | - | 7 years | |
| Dwight Mater | M | - | 6 years | |
| Sharon Luboff | F | - | 10 years | |
| Kent Stemper | M | - | 13 years | |
| Charles J. Hansen | M | 76 | 5 years | |
| Bill Gantz | M | 86 | 26 years | |
| John A. Bardis | M | 67 | 9 years | |
| John W. Colloton | M | 93 | 14 years | |
| Terrence J. Mulligan | M | 78 | 26 years | |
| Peter Farrell | M | 81 | 5 years | |
| Donald Middlebrook | M | 73 | 15 years | |
| Sam Leno | M | 78 | 23 years | |
| Stephen Hoffman | M | 70 | 3 years | |
| Tony White | M | 77 | 9 years | |
| John Steven Sonnier | M | - | - | |
| John Weiland | M | 68 | 1 years | |
| Susan Ross Morton | F | 65 |
University of Aston
| 2 years |
| Marianne T. Armstrong | M | 69 |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | 1 years |
| Alan Montgomery | M | 70 |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | 7 years |
| Tom H. Quinn | M | 76 | 2 years | |
| R. Huennekens | M | 59 | 4 years | |
| Hing Wong | M | 70 | 4 years | |
| Mark Esling | M | - |
University of Aston
| 4 years |
| Bee-Yau Huang | F | - | - | |
| Peter Rhode | M | 66 | 5 years | |
| Robert J. Deans | M | 71 | 6 years | |
| Terry N. Layton | M | - | 2 years | |
| Kathryn A. Tunstall | F | 73 | 7 years | |
| Brent Hatzis-Schoch | M | 59 | 4 years | |
| Fredric I. Orkin | M | - | 7 years | |
| Steve P. Putnam | M | - |
University of Aston
| 1 years |
| Ronald H. Abrahams | M | - | 4 years | |
| Obi Greenman | M | 57 | 4 years | |
| Matthew Gantz | M | 59 |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | 4 years |
| James Murray | M | - |
University of Aston
| 4 years |
| Richard Epstein | M | - | 6 years | |
| Ramon M. Perez | M | 70 | 16 years | |
| Kevin Swan | M | - | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 60 | 77.92% |
| United Kingdom | 17 | 22.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Peter Short
- Personal Network
